Concepedia

Chuck Bullock

CB

Statistics

Publications

3

Citations

344

H-Index

3

Active since

1999

Affiliations

PDL BioPharma (United States)(Current)

Chuck Bullock is an author at PDL BioPharma (United States) specializing in hla, allergy, and histocompatibility.

Top concepts

HlaAllergyMedicinePathologyImmunologyAutoimmunityPharmacologyImmunotherapyImmunomodulationAutoimmune Disease

Publications per year

1999–2004

3

Publications

3

Engineered Human IgG Antibodies with Longer Serum Half-lives in Primates

Paul R. Hinton, Mary G. Johlfs, Joanna M. Xiong et al. · Journal of Biological Chemistry · 2004 · 271 citations · Full text

A HUMANIZED ANTI-CD3 ANTIBODY, HuM291, WITH LOW MITOGENIC ACTIVITY, MEDIATES COMPLETE AND REVERSIBLE T-CELL DEPLETION IN CHIMPANZEES

Di‐Hwei Hsu, Jia Shi, Margit Homola et al. · Transplantation · 1999 · 45 citations

In Vivo Pharmacodynamic Effects of Hu1D10 (Remitogen), a Humanized Antibody Reactive Against a Polymorphic Determinant of HLA-DR Expressed on B Cells

Jia Shi, Chuck Bullock, William C. Hall et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2002 · 28 citations

Hla, Histocompatibility, Laboratory Immunology +21

1–3 of 3